{"id":"W2341475099","doi":"10.1200/jco.2005.23.16_suppl.3127","title":"A phase II study of UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A Princess Margaret Phase II Consortium Trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Neutropenia; Ovarian cancer; Internal medicine; Febrile neutropenia; Chemotherapy; Phases of clinical research; Oncology; Anemia; Toxicity; Surgery; Cancer; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002550052,0.00119222,0.00184105,0.0004242577,0.0004777921,0.001026513,0.001190355,0.001403881,0.003475911],"category_scores_gemma":[0.001144012,0.0005980674,0.001105558,0.0005770134,0.000872834,0.0007115877,0.0004415067,0.002839998,0.0008138954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009836128,"about_ca_system_score_gemma":0.002039104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001388941,"about_ca_topic_score_gemma":0.003517275,"domain_scores_codex":[0.9993033,0.0004409149,0.00002432831,0.00007771856,0.00006951395,0.00008408686],"domain_scores_gemma":[0.9990258,0.0001247045,0.0001859649,0.00008188791,0.000070259,0.000511314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7491423,0.07422,0.01354557,0.001393706,0.002263667,0.0006786844,0.0005292298,0.003257555,0.03707146,0.0004264782,0.008242222,0.1092291],"study_design_scores_gemma":[0.6648726,0.3111064,0.0166861,0.00004119957,0.0003898136,0.0004738845,0.00007208902,0.001409509,0.001640822,0.0001185263,0.003155274,0.0000338392],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917514,0.002067173,0.0003225743,0.0006799232,0.00007105254,0.002697428,0.000689659,0.00006373064,0.001657049],"genre_scores_gemma":[0.9841518,0.002594647,0.001975848,0.001368758,0.0001817234,0.00371747,0.002819482,0.00003195121,0.003158245],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003475911,"threshold_uncertainty_score":0.01348615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06667616169456882,"score_gpt":0.4599364877177345,"score_spread":0.3932603260231657,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}